Novo, Orbis sign up to $1.4 billion deal to develop oral drugs
By Siddhi Mahatole Sept 17 (Reuters) - Orbis Medicines said on Thursday it had signed a drug discove...
17th September, 2026
By Siddhi Mahatole Sept 17 (Reuters) - Orbis Medicines said on Thursday it had signed a drug discove...
17th September, 2026
LONDON, Sept 17 (Reuters) - AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer trea...
17th September, 2026
Sept 17 (Reuters) - French healthcare provider Ramsay Generale de Sante expects its revenue to grow...
17th September, 2026
By Sam Tobin LIVERPOOL, England, Sept 15 (Reuters) - British nurse Lucy Letby was able to murder sev...
15th September, 2026
LONDON, Sept 11 (Reuters) - Kate, Britain's Princess of Wales, said on Friday her fundraising effort...
11th September, 2026
By Anastasiia Kozlova and Amir Orusov Aug 24 (Reuters) - Sonova launched its third hearing-aid platf...
24th August, 2026
By Vera Dvorakova and Jesus Calero Aug 20 (Reuters) - Danish biosolutions maker Novonesis expects re...
20th August, 2026
CHICAGO, Aug 19 (Reuters) - Merck and Moderna's success with a personalized cancer vaccine designed...
19th August, 2026
By Mahmoud Issa and Alexander Cornwell Deir al-Balah, GAZA/TEL AVIV, July 28 (Reuters) - Israel's mi...
1st August, 2026
By Luiza Ilie BUCHAREST, July 28 (Reuters) - Thousands of Romanian doctors, nurses and other health...
28th July, 2026
MILAN, July 27 (Reuters) - The private equity arm of Goldman Sachs has agreed to acquire control of...
27th July, 2026
By Maggie Fick LONDON, July 21 (Reuters) - Novo Nordisk said on Tuesday it was suing rival Eli Lilly...
21st July, 2026